Skip to main content

Table 1 Baseline demographic and clinical characteristics of the patients

From: Observational multicenter study to evaluate the prevalence and prognosis of subclinical atheromatosis in a Spanish chronic kidney disease cohort: baseline data from the NEFRONA study

 

Controls

CKD

CKD stage 3

CKD stages 4-5

CKD stage 5D

p value

p value

 

n =559

n =2445

n =937

n =820

n =688

CKD vs controls

Between CKD groups

Male gender

298 (53.3)

1509 (61.7)

621 (66.3)

478 (58.3)

409 (59.4)

<0.001

<0.001

Age (years)

54.6 ± 11.5

57.9 ± 12.8

60.9 ± 11.4

58.7 ± 12.3

53.2 ± 13.8

<0.001

<0.001

Clinical history

       

Familial history of CVD

62 (11.1)

213 (8.7)

93 (9.9)

73 (8.9)

47 (6.8)

NS

NS

Current smoker

109 (19.5)

474 (19.4)

177 (18.9)

158 (19.3)

175 (20.2)

NS

NS

Former smoker

228 (40.8)

862 (35.3)

343 (36.6)

279 (34.0)

204 (34.9)

NS

NS

Hypertension

197 (35.2)

2183 (89.3)

827 (88.3)

766 (93.4)

590 (85.8)

<0.001

<0.001

Diabetes mellitus

61 (10.9)

628 (25.7)

258 (27.5)

246 (30.0)

124 (18.0)

<0.001

<0.001

Dyslipidemia

196 (35.1)

1587 (64.9)

657 (70.1)

567 (69.1)

363 (52.8)

<0.001

<0.001

CKD etiology

N/A

    

N/A

<0.001

Vascular

 

471 (19.3)

272 (29.1)

128 (15.6)

71 (10.3)

  

Glomerular

 

381 (15.6)

110 (11.8)

150 (18.3)

121 (17.6)

  

Diabetic

 

351 (14.4)

126 (13.5)

145 (17.7)

80 (11.6)

  

Tubulointerstitial

 

287 (11.7)

94 (10.4)

100 (12.2)

93 (13.5)

  

Cystic

 

239 (9.8)

58 (6.2)

85 (10.4)

96 (14.0)

  

Other

 

307 (12.5)

103 (10.6)

102 (12.4)

102 (14.8)

  

Unknown

 

407 (16.7)

172 (18.4)

110 (13.4)

125 (18.2)

  
  1. Data expressed in number (%) or mean value ± standard deviation. Abbreviations: CKD chronic kidney disease, CVD cardiovascular disease, NS not significant, N/A not assessed.